Skip to main content

Main menu

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
    • CE Credits
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
  • Other Publications
    • The Journal of Applied Laboratory Medicine

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
Clinical Chemistry
  • Other Publications
    • The Journal of Applied Laboratory Medicine
  • Subscribe
  • My alerts
  • Log in
Clinical Chemistry

Advanced Search

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
    • CE Credits
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
OtherTechnical Brief

Mass Spectrometry–Based Detection of Hemoglobin E Mutation by Allele-Specific Base Extension Reaction

Jason C.H. Tsang, Pimlak Charoenkwan, Katherine C.K. Chow, Yongjie Jin, Chanane Wanapirak, Torpong Sanguansermsri, Y.M. Dennis Lo, Rossa W.K. Chiu
DOI: 10.1373/clinchem.2007.095133 Published November 2007
Jason C.H. Tsang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pimlak Charoenkwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine C.K. Chow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongjie Jin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chanane Wanapirak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Torpong Sanguansermsri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y.M. Dennis Lo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rossa W.K. Chiu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: The specific detection of a minor population of mutant DNA molecules requires methods of high specificity and sensitivity. While the single-allele base extension reaction (SABER) was shown to be useful for the detection of certain beta-thalassemia mutations, we encountered problems with false positivity during development of SABER for the noninvasive prenatal diagnosis of the hemoglobin E (HbE) disease. Systematic optimization resulted in an alternative protocol, the allele-specific base extension reaction (ASBER).

Methods: An artificial model was established by mixing genomic DNA of HbE carriers and normal individuals. Effects of terminator concentration and annealing temperature on the nonspecificity of SABER were then studied. The use of a single relevant terminator and the other 3 types of dideoxynucleotide as competing terminators were also compared in the development of the ASBER protocol. Thirteen cases of HbE-susceptible pregnancies were tested to compare the SABER and the ASBER protocols.

Results: Decreasing the single relevant terminator concentration and increasing the annealing temperature in SABER were found to improve specificity. The use of the other 3 types of dideoxynucleotide as competing terminators was shown to offer better detection sensitivity than a single terminator in ASBER. Genotyping results were all correctly determined by ASBER, except one false-negative detection (sensitivity: 80%, specificity: 100%).

Conclusions: An alternative mass spectrometry–based protocol for noninvasive prenatal diagnosis, ASBER, has been successfully developed to allow the detection of a minor DNA population with a point mutation.

The discovery of circulating fetal nucleic acids in maternal plasma has opened up exciting possibilities for noninvasive prenatal diagnosis(1)(2). The recent development of the mass spectrometry-based single-allele base extension reaction (SABER) protocol has enabled sensitive differentiation of fetal-specific alleles down to a single-nucleotide level(3)(4)(5). In this report, we intended to develop a mass spectrometry–based method for the noninvasive prenatal diagnosis of the hemoglobin E (HbE) mutation. Unexpectedly, the lack of specificity of SABER for the HbE mutation was discovered during assay development, and systematic optimization on an artificial model has been carried out. This development has resulted in an alternative protocol, the allele-specific base extension reaction (ASBER).

HbE disease is an autosomal recessive hemoglobinopathy caused by a (GAG→AAG) missense mutation in codon 26 of the β-globin gene(6). It is the most common thalassemic hemoglobinopathy in Southeast Asia(7). Although homozygotes of HbE are mildly affected by the mutation, compound heterozygotes of the HbE and the β-thalassemia mutation will result in severe anemia (HbE/β-thalassemia). Therefore, detection of the HbE mutant allele is critically important in the prenatal diagnosis of thalassemia major in Southeast Asia. In noninvasive prenatal diagnosis of HbE, the absence of the paternally transmitted fetal HbE mutant allele in the plasma of a pregnant female carrier of a β-thalassemic mutation negates the fetal inheritance of HbE/β-thalassemia. Theoretically, this suggests that 50% of invasive procedures are unnecessary and can thus be avoided.

All samples in this study were collected with informed consent, and approval was granted by the institutional ethics committee. Venous blood (6 mL) was collected into EDTA tubes from each couple referred for prenatal diagnosis. Plasma and buffy coat were harvested from blood samples after a 1st centrifugation at 1600g for 10 min and a further microcentrifugation of plasma aliquot at 16 000g for 10 min as previously described(8). DNA was extracted from buffy coat and 800 μL of plasma by a Nucleon Blood DNA Extraction Kit (GE Healthcare) and a QIAamp Blood Mini Kit (Qiagen) with elution volume of 50 μL H2O, respectively, according to the manufacturers’ recommendations.

The principle of standard homogenous MassEXTEND (Sequenom) and SABER protocols have been described previously(3). HotStar Taq polymerase (Qiagen) was used in the PCR at a final volume of 25 μL, containing 10 μL of plasma DNA and 0.2 μmol/L PCR primers (Integrated DNA Technologies). The thermal profile was 95 °C for 15 min for hot start, 45 cycles of denaturing at 95 °C for 20 s, annealing at 58 °C for 30 s, and extension at 72 °C for 1 min, followed by a final incubation at 72 °C for 3 min. PCR products were then treated with shrimp alkaline phosphatase (Sequenom) for 40 min at 37 °C to remove unreacted dNTPs. Base extension reaction was carried out with thermosequenase (Sequenom) on 10 μL of shrimp alkaline phosphatase–treated PCR product in a final reaction volume of 14 μL, with 1.54 μmol/L of the extension primer (Integrated DNA Technologies) and a terminator mix of dideoxy/deoxynucleotides, each at 64 μmol/L. The thermal profile consisted of 94 °C for 2 min, followed by a rapid thermocycling for 75 cycles at 94 °C, 52 °C, and 74 °C, all for 5 s. Products were then analyzed by the MassARRAY™ Analyzer Compact Mass Spectrometer (Brucker), a MALDI-TOF system. Details of the PCR primers, termination mix, and extension primers are listed in the Data Supplement that accompanies the online version of this Technical Brief at http://www.clinchem.org/content/vol53/issue12.

Thirteen HbE-negative pregnant participants (gestational age: 16–22 weeks) with male partners being HbE carriers were recruited. Genotypes of the couples and the fetuses were confirmed by analysis of buffy coat and cord blood samples, respectively, by the standard homogenous MassEXTEND protocol. Five of the fetuses were shown to be HbE positive.

Genotyping results of the SABER protocol on maternal plasma showed nonspecificity (see Fig. 1 in the Data Supplement). All 8 informative-negative pregnancies were misclassified as positive. To evaluate the important analytical parameters for the nonspecificity of SABER, an artificial model was established. Genomic DNA of a male HbE carrier was mixed with wild-type maternal genomic DNA to mimic the plasma DNA of an affected pregnancy. Direct dilution of wild-type maternal genomic DNA was used to mimic plasma DNA of normal pregnancy. Systematic evaluation revealed that the terminator concentration and the annealing temperature in the base extension reaction were critical for the reduction of false-positive detection in SABER. A 50-fold dilution of the standard terminator concentration and annealing temperature at 66 °C were shown to be optimal for both specific and sensitive detection of the HbE mutation in the artificial model (Table 1⇓ ).

We explored the development of an alternative protocol, ASBER. The 3′ end of the extension primer for ASBER was engineered to be complementary to the fetal mutant allele. Hence, primer extension of the maternal wild-type allele would be inhibited by 3′-primer-template mismatch (Fig. 1A⇓ ). Initially, the use of a single relevant terminator (ddA only) at standard concentration also revealed nonspecificity (data not shown). Thus, terminator dilution and the introduction of competing terminators (ddA, ddC, ddG, and ddT, each at 64 μmol/L) in the ASBER protocol were evaluated. Both the use of competing terminators and 20-fold dilution of the relevant terminator were found to provide specific genotyping results. However, the use of competing terminators appears to offer better detection sensitivity on the artificial model with different percentage mix of mutant DNA (Fig. 1B⇓ ). The design of ASBER with competing terminators was adopted to reanalyze the 13 maternal plasma samples, and the fetal genotypes were all correctly determined except 1 case of false-negative result.

In this study, we have shown that for certain mutational context, SABER might generate nonspecific results due to incorporation of the single terminator in the extension reaction mixture despite it being noncomplement to the template PCR product. Although the mechanism behind this nonspecificity or misincorporation is still unclear, we hypothesize that the intrinsic specificity of SABER is a subtle balance between the fidelity of the polymerase and the degree of excess of the single relevant terminator in the primer extension reaction mixture(9). The lower the polymerase fidelity and the higher the terminator concentration promote misincorporation. Based on this reasoning, optimization can be achieved by adjusting the terminator concentration as described above (Table 1A⇓ ). Others have shown that the polymerase fidelity could be improved by using a proofreading polymerase(9). However, this method did not offer any improvement in the specific detection of the trace amount of fetal DNA in maternal plasma in our preliminary findings (data not shown). On the other hand, we showed that nonspecificity of SABER was reduced by increasing the annealing temperature for base extension (Table 1B⇓ ). This result might be because the environment becomes less favorable for misincorporation of the noncomplementary terminator.

To overcome the intrinsic tendency of terminator misincorporation in SABER, we explored and developed ASBER based on the principle of allele-specific primer extension, which has been reported to offer successful mass spectrometry–based mutation genotyping(10)(11). However, such design has not been applied to specific fetal allele detection in noninvasive prenatal diagnosis. Compared with previous studies(10)(11), specific priming of the fetal-specific allele in noninvasive prenatal diagnosis is less favorable due to the overwhelming background of maternal allele and the lack of priming competition from alternative allele-specific primer. Yet we expect better specificity in ASBER than the conventional allele-specific PCR(12), because the ASBER extension products would not serve as templates for further amplification. Thus, a misprimed ASBER product, if it occurs, would not be exponentially propagated. Nevertheless, false-positive detection is also detectable in ASBER with the single relevant terminator and therefore required optimization. False-positive detection was not observed in ASBER with competing terminators. This finding further suggested that an overdominance of any single terminator in the extension mixture promotes misincorporation. Further comparison of detection sensitivity of the 2 ASBER protocols shows that improving specificity by reduction of the fractional concentration of a terminator (i.e., inclusion of 3 other types of dideoxynucleotide as competing terminators) is better than dilution of the relevant terminator (Fig. 1B⇓ ).

Reanalysis of the 13 pregnancies at risk for HbE/β-thalassemia with the ASBER protocol showed substantial improvement in specificity compared with the SABER protocol, with 1 false-negative result. The diagnostic performance of the HbE ASBER assay needs to be confirmed with larger-scale studies.

In summary, we have successfully developed ASBER, which confers advantages in terms of specificity and sensitivity over SABER for the detection of the HbE mutation. Using this approach, noninvasive prenatal diagnosis of the HbE mutation has been achieved with a specificity of 100% (8 of 8) and a sensitivity of 80% (4 of 5). To further improve the sensitivity of the assay, potential fetal allele enrichment steps—for example, PCR clamping by PNA probe and size fractionation—can be included(13). We speculate that the application of the ASBER protocol can be extended to other fields of circulating nucleic acids, for instance, detection of circulating tumor-specific DNA in cancer patients such as KRAS point mutations(14) and detection of circulating donor-specific DNA in transplant recipients(15).

View this table:
  • View inline
  • View popup
Table 1.

Comparing the percentage of false-positive detection and true-positive detection of SABER at different terminator concentrations (A) and annealing temperatures (B).

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

Comparison between the SABER and ASBER protocols.

(A), Schematic diagram comparing the principles of the SABER and ASBER protocols. The site of the point mutation is indicated in capital letters. The boxed letter indicates the type of dideoxynucleotide terminator in the base extension reaction. (B), grouped bar chart comparing detection sensitivity of different protocol designs on artificial plasma model with different concentrations. Eight separate PCRs were performed for a particular concentration of artificial mutant and wild-type allele mix followed by 8 separate base extension reactions. The base extension products were then analyzed in duplicate by the MassARRAY™ system. A reaction was scored positive if 1 of the duplicates was called by the TyperAnalyzer software (Sequenom). The sensitivity was then calculated as the percentage of positive detection out of the 8 separate PCRs.

Acknowledgments

Grant/funding support: This work was supported by an Earmarked Research Grant (CUHK4395/03M) from the Research Grants Council of the Hong Kong Special Administrative Region, China. Y.M.D.L. is supported by the Chair Professorship Scheme of the Li Ka Shing Foundation.

Financial disclosures: Y.M.D.L. and R.W.K.C. hold patents and have filed patent applications on aspects of the use of fetal nucleic acids in maternal plasma for noninvasive prenatal diagnosis, a proportion of which has been licensed to Sequenom, Inc. Y.M.D.L. is a consultant for Sequenom Inc.

  • © 2007 The American Association for Clinical Chemistry

References

  1. ↵
    Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487.
    OpenUrlCrossRefPubMed Order article via Infotrieve
  2. ↵
    Lo YMD, Chiu RWK. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 2007;8:71-77.
    OpenUrlCrossRefPubMed Order article via Infotrieve
  3. ↵
    Ding C, Chiu RWK, Lau TK, Leung TN, Chan LC, Chan AY, et al. MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc Natl Acad Sci U S A 2004;101:10762-10767.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Li Y, Page-Christiaens GC, Gille JJ, Holzgreve W, Hahn S. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn 2007;27:11-17.
    OpenUrlCrossRefPubMed Order article via Infotrieve
  5. ↵
    Li Y, Wenzel F, Holzgreve W, Hahn S. Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation. Electrophoresis 2006;27:3889-3896.
    OpenUrlCrossRefPubMed Order article via Infotrieve
  6. ↵
    Orkin SH, Kazazian HH, Jr, Antonarakis SE, Ostrer H, Goff SC, Sexton JP. Abnormal RNA processing due to the exon mutation of beta E-globin gene. Nature 1982;300:768-769.
    OpenUrlCrossRefPubMed Order article via Infotrieve
  7. ↵
    Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin 1987;11:65-88.
    OpenUrlPubMed Order article via Infotrieve
  8. ↵
    Chiu RWK, Poon LL, Lau TK, Leung TN, Wong EM, Lo YMD. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001;47:1607-1613.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Di Giusto D, King GC. Single base extension (SBE) with proofreading polymerases and phosphorothioate primers: improved fidelity in single-substrate assays. Nucleic Acids Res 2003;31:e7.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Blievernicht JK, Schaeffeler E, Klein K, Eichelbaum M, Schwab M, Zanger UM. MALDI-TOF mass spectrometry for multiplex genotyping of CYP2B6 single-nucleotide polymorphisms. Clin Chem 2007;53:24-33.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Higgins GS, Little DP, Koster H. Competitive oligonucleotide single-base extension combined with mass spectrometric detection for mutation screening. Biotechniques 1997;23:710-714.
    OpenUrlPubMed Order article via Infotrieve
  12. ↵
    Wu DY, Ugozzoli L, Pal BK, Wallace RB. Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci U S A 1989;86:2757-2760.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005;293:843-849.
    OpenUrlCrossRefPubMed Order article via Infotrieve
  14. ↵
    Anker P, Lefort F, Vasioukhin V, Lyautey J, Lederrey C, Chen XQ, et al. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 1997;112:1114-1120.
    OpenUrlCrossRefPubMed Order article via Infotrieve
  15. ↵
    Lo YMD, Tein MS, Pang CC, Yeung CK, Tong KL, Hjelm NM. Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet 1998;351:1329-1330.
    OpenUrlCrossRefPubMed Order article via Infotrieve
View Abstract
PreviousNext
Back to top

In this issue

Clinical Chemistry: 53 (12)
Vol. 53, Issue 12
December 2007
  • Table of Contents
  • Index by author
  • Table of Contents (PDF)
Print
Share
Mass Spectrometry–Based Detection of Hemoglobin E Mutation by Allele-Specific Base Extension Reaction
Jason C.H. Tsang, Pimlak Charoenkwan, Katherine C.K. Chow, Yongjie Jin, Chanane Wanapirak, Torpong Sanguansermsri, Y.M. Dennis Lo, Rossa W.K. Chiu
Clinical Chemistry Dec 2007, 53 (12) 2205-2209; DOI: 10.1373/clinchem.2007.095133
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Mass Spectrometry–Based Detection of Hemoglobin E Mutation by Allele-Specific Base Extension Reaction
Jason C.H. Tsang, Pimlak Charoenkwan, Katherine C.K. Chow, Yongjie Jin, Chanane Wanapirak, Torpong Sanguansermsri, Y.M. Dennis Lo, Rossa W.K. Chiu
Clinical Chemistry Dec 2007, 53 (12) 2205-2209; DOI: 10.1373/clinchem.2007.095133

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Detection of Factor VIII Gene Mutations by High-Resolution Melting Analysis
  • Effects of 7 Hemoglobin Variants on the Measurement of Glycohemoglobin by 14 Analytical Methods
Show more Technical Briefs

Similar Articles

Options

  • Home
  • About
  • Articles
  • Information for Authors
  • Resources
  • Abstracts
  • Submit
  • Contact
  • RSS

Other Publications

  • The Journal of Applied Laboratory Medicine
Footer logo

© 2019 American Association for Clinical Chemistry

Powered by HighWire